Mineralocorticoid receptor agonist aldosterone rescues hippocampal neural stem cell proliferation defects and improves postoperative cognitive function in aged mice-Reference-Cited by-同舟云学术

Mineralocorticoid receptor agonist aldosterone rescues hippocampal neural stem cell proliferation defects and improves postoperative cognitive function in aged mice

Published:2022-06-14 Issue:2 Volume:24 Page:149-161
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Fan Xuhong¹,Zhao Zhenyu²,Huang Zixia¹,Wu Mingyue¹,Wang Deming¹,Xiao Ji¹

Affiliation:

1. Department of Anesthesiology, The Second Affiliated Hospital of University of South China, Hengyang, China

2. Department of Anesthesiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China

Funder

National Natural Science Foundation of China

Hunan Provincial Science and Technology Department

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/15622975.2022.2082524

Reference55 articles.

1. Regulation and Function of Adult Neurogenesis: From Genes to Cognition

2. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity

3. Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways

4. Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model

5. Association between APOE epsilon 4 allele and postoperative cognitive dysfunction: A meta-analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. D-Pinitol mitigates post-traumatic stress disorder-like behaviors induced by single prolonged stress in mice through mineralocorticoid receptor antagonism;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-06

2. Xiaotangzhike Pill Attenuates the Progression of Diabetes In Vivo through the Mediation of the Akt/GSK-3β Axis;Evidence-Based Complementary and Alternative Medicine;2022-12-21